Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A45650 | 23448493 | Curr Pharm Des | Endothelial dysfunction in morbid obesity. | 2013 | Details |
| A45651 | 23448486 | Curr Pharm Des | Role of adiponectin in the metabolic syndrome: current perspectives on its modulation as a treatment strategy. | 2013 | Details |
| A45666 | 23374710 | Vitam Horm | Hormonal regulation of lipogenesis. | 2013 | Details |
| A45669 | 23352427 | Can J Cardiol | Reply to Mirrakhimov and Mirrakhimov--nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents. | 2013 | Details |
| A45690 | 23265092 | Can J Cardiol | Nonalcoholic fatty liver disease and cardiovascular risk: is there a place for obstructive sleep apnea? | 2012 | Details |
| A45719 | 23111985 | Hepatology | Circulating MicroRNA-122 signature in nonalcoholic fatty liver disease and cardiovascular disease: a new endocrine system in metabolic syndrome. | 2013 | Details |
| A45722 | 23093702 | Endocrinology | Additive effects of nicotine and high-fat diet on hepatic steatosis in male mice. | 2012 | Details |
| A45737 | 31186864 | Clin Liver Dis (Hoboken) | Assessment and management of comorbidities (including cardiovascular disease) in patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A45752 | 22957215 | J Obes | An update on less invasive and endoscopic techniques mimicking the effect of bariatric surgery. | 2012 | Details |
| A45771 | 22840429 | Atherosclerosis | Non-alcoholic fatty liver disease and cardiovascular disease. | 2012 | Details |
| A45775 | 22813567 | Diabetes Metab Syndr | Insulin resistance and alanine amino transaminase (ALT) levels in first degree relatives of type 2 diabetes mellitus. | 2012 | Details |
| A45807 | 22646861 | Expert Opin Drug Discov | Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk. | 2011 | Details |
| A45809 | 25083232 | Ther Adv Drug Saf | Safety of statins: an update. | 2012 | Details |
| A45822 | 22527892 | Endocrine | Anti-oxidant therapy in non-alcoholic fatty liver disease: the role of silymarin. | 2012 | Details |
| A45826 | 22505369 | Hepatology | Cardiovascular phenotype of nonalcoholic fatty liver disease: hanging the paradigm about the role of distant toxic fat accumulation on vascular disease. | 2012 | Details |
| A45834 | 22471112 | Rev Med Suisse | [Lipid-lowering treatment and liver dysfunction]. | 2012 | Details |
| A45851 | 22387255 | Clin Gastroenterol Hepatol | Nonalcoholic fatty liver disease and cardiovascular disease risk. | 2012 | Details |
| A45855 | 22371327 | Hepatology | Diagnostic accuracy of adipose insulin resistance index and visceral adiposity index for progressive liver histology and cardiovascular risk in nonalcoholic fatty liver disease. | 2012 | Details |
| A45869 | 22285146 | Dig Liver Dis | Screening for liver fibrosis by using FibroScan(®) and FibroTest in patients with diabetes. | 2012 | Details |
| A45886 | 24713805 | Ann Gastroenterol | Cardiovascular disease in patients with non-alcoholic fatty liver disease. | 2012 | Details |
| A45909 | 22130312 | Clin Chim Acta | Thyroid function in childhood obesity and metabolic comorbidity. | 2011 | Details |
| A45929 | 22005190 | Adv Cardiol | Metabolic disorders associated with obstructive sleep apnea in adults. | 2011 | Details |
| A45935 | 21969091 | Hepatology | Mean platelet volume as a marker of increased cardiovascular risk in patients with nonalcoholic steatohepatitis. | 2012 | Details |
| A45942 | 21941075 | J Postgrad Med | Nonalcoholic fatty liver disease in south India. | 2012 | Details |
| A45968 | 21788578 | Diabetes | The metabolically benign and malignant fatty liver. | 2011 | Details |
| A45970 | 21775769 | Arterioscler Thromb Vasc Biol | Steatosis DeLIVERs high-sensitivity C-reactive protein. | 2011 | Details |
| A45977 | 21760736 | Diabetes Metab Syndr Obes | Diet-induced metabolic hamster model of nonalcoholic fatty liver disease. | 2011 | Details |
| A45988 | 21713308 | Cardiovasc J Afr | Serving diabetes and cardiology: round three of the South African diabetologist/cardiologist debate. | 2011 | Details |
| A45990 | 21710476 | Hepatology | Treatment implication from the potential association between nonalcoholic fatty liver disease and cardiovascular disease. | 2011 | Details |
| A46008 | 21604916 | Ann Med | The Finnish Diabetes Risk Score (FINDRISC) and other non-invasive scores for screening of hepatic steatosis and associated cardiometabolic risk. | 2011 | Details |
| A46010 | 21599573 | Ann Med | Effects of moderate red wine consumption on liver fat and blood lipids: a prospective randomized study. | 2011 | Details |
| A46014 | 21525484 | Diabetes Care | Lipids in the wrong place: visceral fat and nonalcoholic steatohepatitis. | 2011 | Details |
| A46021 | 21520192 | Hepatology | Insulin resistance links nonalcoholic fatty liver to cardiovascular diseases. | 2011 | Details |
| A46043 | 21441697 | Circ J | Prevention of atherosclerosis in overweight/obese patients. - In need of novel multi-targeted approaches-. | 2011 | Details |
| A46052 | 21404982 | Am Fam Physician | Considerations for safe use of statins: liver enzyme abnormalities and muscle toxicity. | 2011 | Details |
| A46076 | 21254340 | Liver Transpl | Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. | 2011 | Details |
| A46089 | 21160986 | World J Hepatol | Liver function tests: Association with cardiovascular outcomes. | 2010 | Details |
| A46099 | 21105450 | Vnitr Lek | [Complications of obesity--pathogenesis]. | 2010 | Details |
| A46118 | 20965008 | Actas Dermosifiliogr | [Nonalcoholic fatty liver disease and psoriasis]. | 2010 | Details |
| A46126 | 20879883 | N Engl J Med | Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. | 2010 | Details |
| A46133 | 20827721 | Hepatology | Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease. | 2010 | Details |
| A46157 | 20672381 | Hepatology | Suggestion of a dual-functional agent for future trials in nonalcoholic fatty liver disease. | 2010 | Details |
| A46177 | 20566726 | CMAJ | Newly diagnosed diabetes mellitus as a risk factor for serious liver disease. | 2010 | Details |
| A46194 | 20446347 | Curr Opin Anaesthesiol | Metabolic syndrome: anesthesia for morbid obesity. | 2010 | Details |
| A46198 | 20415823 | Dermatol Ther | Psoriasis, the liver, and the gastrointestinal tract. | 2010 | Details |
| A46202 | 20391295 | Semin Thromb Hemost | Disorders of coagulation and hemostasis in abdominal obesity: emerging role of fatty liver. | 2010 | Details |
| A46209 | 20371660 | J Clin Endocrinol Metab | Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease. | 2010 | Details |
| A46211 | 20360293 | Mayo Clin Proc | Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma. | 2010 | Details |
| A46219 | 20217240 | Mol Biol Rep | Oxidative stress induced by high-glucose diet in liver of C57BL/6J mice and its underlying mechanism. | 2010 | Details |
| A46224 | 20207207 | Dig Liver Dis | Prevention and treatment of nonalcoholic fatty liver disease. | 2010 | Details |
| A46225 | 20197789 | Eur J Clin Nutr | Berry meals and risk factors associated with metabolic syndrome. | 2010 | Details |
| A46272 | 19877024 | Liver Transpl | Obesity, hyperlipidemia, and metabolic syndrome. | 2009 | Details |
| A46280 | 19802516 | J Gastroenterol | The intertwisted correlations among non-alcoholic fatty liver disease, atherosclerosis, and metabolic syndrome. | 2009 | Details |
| A46288 | 19767790 | Appl Physiol Nutr Metab | Physical activity and abdominal obesity in youth. | 2009 | Details |
| A46293 | 19738529 | South Med J | The association of obesity, metabolic syndrome, diabetes, and cardiovascular disease with nonalcoholic fatty liver disease. | 2009 | Details |
| A46296 | 19713981 | Nat Rev Gastroenterol Hepatol | Nonalcoholic fatty liver disease: Disease and comorbidity--effects on quality of life. | 2009 | Details |
| A46299 | 19702897 | J Gastroenterol Hepatol | Clues from the carotids: an appraisal of cardiovascular disease risk in non-alcoholic fatty liver disease. | 2009 | Details |
| A46300 | 19700042 | Clin Chest Med | The obesity epidemic. | 2009 | Details |
| A46320 | 19555426 | Cardiovasc Ther | Prescribing statins to patients with nonalcoholic fatty liver disease: real cardiovascular benefits outweigh theoretical hepatotoxic risk. | 2009 | Details |
| A46325 | 19541924 | Am J Physiol Gastrointest Liver Physiol | Trans fat feeding results in higher serum alanine aminotransferase and increased insulin resistance compared with a standard murine high-fat diet. | 2009 | Details |
| A46327 | 19539084 | Am J Cardiol | A comparison of the prevalence of the MS and its complications using three proposed definitions in Korean subjects. | 2009 | Details |
| A46328 | 19506316 | ILAR J | Metabolic consequences of sleep-disordered breathing. | 2009 | Details |
| A46366 | 19284314 | Metab Syndr Relat Disord | Metabolic syndrome and cancer. | 2009 | Details |
| A46367 | 19271298 | J Pediatr Gastroenterol Nutr | Intestinal microbiota during infancy and its implications for obesity. | 2009 | Details |
| A46369 | 19262374 | Curr Opin Endocrinol Diabetes Obes | Nonalcoholic fatty liver disease in type 2 diabetes mellitus. | 2009 | Details |
| A46373 | 19232511 | Arch Biochem Biophys | Lipoic acid improves hypertriglyceridemia by stimulating triacylglycerol clearance and downregulating liver triacylglycerol secretion. | 2009 | Details |
| A46386 | 19131468 | Diabetes Care | Synergy between adiposity, insulin resistance, metabolic risk factors, and inflammation in adolescents. | 2009 | Details |
| A46395 | 19062531 | Genetika | [Adipokine genetics: unbalanced protein secretion by human adipose tissue as a cause of the metabolic syndrome]. | 2008 | Details |
| A46399 | 19037170 | J Prev Med Public Health | [The association of cardiovascular risk factors with nonalcoholic fatty liver disease in health checkup examinees]. | 2008 | Details |
| A46410 | 21180527 | Therap Adv Gastroenterol | Treatment options for nonalcoholic Fatty liver disease. | 2008 | Details |
| A46412 | 18971485 | Endocr Rev | The metabolic syndrome. | 2008 | Details |
| A46416 | 18827582 | Curr Opin Clin Nutr Metab Care | Nonalcoholic fatty liver disease: the potential role of nutritional management. | 2008 | Details |
| A46437 | 18666246 | Hepatology | Statins in liver disease: a molehill, an iceberg, or neither? | 2008 | Details |
| A46441 | 18636653 | World J Gastroenterol | Liver in systemic disease. | 2008 | Details |
| A46481 | 18367852 | Korean J Hepatol | [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease]. | 2008 | Details |
| A46484 | 18363535 | Pharmacotherapy | Safety of statin therapy in patients with preexisting liver disease. | 2008 | Details |
| A46494 | 18271277 | Wei Sheng Wu Xue Bao | [The intestinal microbiota and obesity of the host]. | 2007 | Details |
| A46498 | 18249212 | Metabolism | Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. | 2008 | Details |
| A46503 | 18209783 | Can J Gastroenterol | Obesity: a review of pathogenesis and management strategies. | 2008 | Details |
| A46506 | 18196992 | Curr Opin Lipidol | Nutrition and metabolism: non-alcoholic fatty liver disease - pathogenesis, cardiovascular risk and therapy. | 2008 | Details |
| A46508 | 18187076 | Am J Med | Carotid artery intima-media thickness in nonalcoholic fatty liver disease. | 2008 | Details |
| A46510 | 30743783 | Expert Rev Endocrinol Metab | Inflammatory biomarkers associated with obesity and insulin resistance: a focus on lipocalin-2 and adipocyte fatty acid-binding protein. | 2008 | Details |
| A46513 | 18092195 | Endocr Res | Nonalcoholic fatty liver disease and diabetes mellitus. | 2007 | Details |
| A46527 | 17932318 | Arterioscler Thromb Vasc Biol | Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis. | 2007 | Details |
| A46536 | 17720354 | Am J Med | Abdominal adiposity and cardiometabolic risk: do we have all the answers? | 2007 | Details |
| A46544 | 17726184 | Diabetes Care | Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. | 2007 | Details |
| A46545 | 17723922 | Clin Liver Dis | Lipid-lowering agents that cause drug-induced hepatotoxicity. | 2007 | Details |
| A46548 | 17675904 | J Cardiometab Syndr | Introduction: organ involvement in the cardiometabolic syndrome. | 2006 | Details |
| A46570 | 17526817 | Diabetes Care | Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients: response to Targher et al. and Hu et al. | 2007 | Details |
| A46571 | 17519430 | Diabetes Care | Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. | 2007 | Details |
| A46574 | 17512312 | Metabolism | Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study. | 2007 | Details |
| A46577 | 17498505 | Gastroenterology | The epidemiology of obesity. | 2007 | Details |
| A46596 | 17388108 | Hellenic J Cardiol | Non-alcoholic fatty liver and cardiovascular disease: an emerging relationship. | 2007 | Details |
| A46599 | 17376033 | J Gastroenterol Hepatol | Predictors of pathological severity in non-alcoholic fatty liver disease: is East meeting West in the middle? | 2007 | Details |
| A46606 | 17331066 | Expert Rev Mol Diagn | Adipokines and melanocortins in the hepatic manifestation of metabolic syndrome: nonalcoholic fatty liver disease. | 2007 | Details |
| A46615 | 17275449 | Am J Med | Polycystic ovary syndrome: diagnosis and treatment. | 2007 | Details |
| A46616 | 17274475 | Pol Arch Med Wewn | [Non-alcoholic fatty liver disease]. | 2006 | Details |
| A46647 | 16912555 | Curr Opin Clin Nutr Metab Care | Assessment of metabolic profile in a clinical setting. | 2006 | Details |
| A46655 | 16828776 | Atherosclerosis | Non-alcoholic fatty liver disease as a determinant of cardiovascular disease. | 2006 | Details |
| A46687 | 16532658 | Future Child | The consequences of childhood overweight and obesity. | 2006 | Details |